首页> 美国卫生研究院文献>Scientific Reports >The strategies and outcomes of left subclavian artery revascularization during thoracic endovascular repair for type B aortic dissection
【2h】

The strategies and outcomes of left subclavian artery revascularization during thoracic endovascular repair for type B aortic dissection

机译:B型主动脉夹层胸腔内修复术中左锁骨下动脉血运重建的策略和结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study was to analyze the outcomes of left subclavian artery (LSA) revascularization during thoracic endovascular repair (TEVAR) for type B aortic dissections (TBAD). From 2011 to 2017, TBAD patients who underwent LSA revascularization during TEVAR were enrolled. Technical success, endoleaks, mortality, complication, reintervention, and patency of target vessels were analyzed. 38 patients were included, 14 underwent carotid-subclavian bypass (CSB), and 24 underwent chimney graft (CG) implantation. Technical success rates were 92.9% and 100% in CSB and CG group. Eleven immediate type I endoleak (EL-I) was detected, including one from CSB group and ten from CG group. Three immediate type II endoleak (EL-II) was detected in CSB group. Perioperative complications showed no difference, but CSB group had longer intensive care unit (ICU) stay time. Median follow-up time was 26.2 months, and overall mortality was 14.3% and 0% in each group. Three EL-I and one EL-II underwent reintervention. All the LSA showed good patency, except one suffered from CG collapse. Both CSB and CG were feasible strategies to preserve the antegrade blood flow of LSA, and each strategy had its advantages and disadvantages. Based on our current experience, we preferred CG for high-risk patients. However, the evidence was still not strong enough, further well-designed studies are necessary to identify the criteria for LSA revascularization strategy during TEVAR.
机译:这项研究旨在分析B型主动脉夹层(TBAD)的胸腔内血管修复(TEVAR)期间的左锁骨下动脉(LSA)血运重建的结果。从2011年至2017年,纳入了在TEVAR期间接受LSA血运重建的TBAD患者。分析了技术成功,内漏,死亡率,并发症,再介入和靶血管通畅性。其中包括38例患者,其中14例接受了颈动脉-锁骨下旁路(CSB),而24例接受了烟囱移植(CG)植入。 CSB和CG组的技术成功率分别为92.9%和100%。检测到11种即时I型内漏(EL-1),其中CSB组1种,CG组10种。 CSB组中检测到三个即时II型内漏(EL-II)。围手术期并发症无差异,但CSB组的重症监护病房(ICU)住院时间更长。中位随访时间为26.2个月,每组总死亡率分别为14.3%和0%。 3架EL-I和1架EL-II进行了再次干预。所有的LSA都显示出良好的通畅性,但其中一个遭受了CG崩溃的影响。 CSB和CG都是保持LSA顺行血流的可行策略,每种策略各有优缺点。根据我们目前的经验,对于高危患者,我们首选CG。但是,证据仍然不足,需要进一步设计良好的研究来确定TEVAR期间LSA血运重建策略的标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号